$ONXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ONYX PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ONYX PHARMACEUTICALS INC. Get notifications about new insider transactions in ONYX PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Sell | S | 132.76 | 8,378 | 1,112,252 | 27,566 | 35.9 K to 27.6 K (-23.31 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Buy | M | 37.68 | 2,388 | 89,980 | 35,944 | 33.6 K to 35.9 K (+7.12 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Buy | M | 35.18 | 1,750 | 61,565 | 33,556 | 31.8 K to 33.6 K (+5.50 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Buy | M | 26.38 | 4,740 | 125,041 | 31,806 | 27.1 K to 31.8 K (+17.51 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 35.18 | 802 | 28,214 | 16,042 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 796 | 29,993 | 25,466 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.69 | 583 | 21,973 | 18,667 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 30.28 | 656 | 19,864 | 5,250 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 32.07 | 1,215 | 38,965 | 13,686 | |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 131.86 | 4,052 | 534,297 | 34,618 | 38.7 K to 34.6 K (-10.48 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 35.18 | 802 | 28,214 | 38,670 | 37.9 K to 38.7 K (+2.12 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 796 | 29,993 | 37,868 | 37.1 K to 37.9 K (+2.15 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 583 | 21,967 | 37,072 | 36.5 K to 37.1 K (+1.60 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 30.28 | 656 | 19,864 | 36,489 | 35.8 K to 36.5 K (+1.83 %) |
Aug 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 32.07 | 1,215 | 38,965 | 35,833 | 34.6 K to 35.8 K (+3.51 %) |
Jul 31 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | S | 131.26 | 1,500 | 196,890 | 2,100 | 3.6 K to 2.1 K (-41.67 %) |
Jul 31 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Sell | S | 131.26 | 1,500 | 196,890 | 2,100 | 3.6 K to 2.1 K (-41.67 %) |
Jul 29 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 76.79 | 2,000 | 153,580 | 0 | |
Jul 29 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | S | 130.50 | 2,000 | 261,000 | 3,600 | 5.6 K to 3.6 K (-35.71 %) |
Jul 29 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 76.79 | 2,000 | 153,580 | 5,600 | 3.6 K to 5.6 K (+55.56 %) |
Jul 29 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 130.50 | 6,043 | 788,612 | 42,795 | 48.8 K to 42.8 K (-12.37 %) |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 796 | 29,993 | 26,262 | |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 583 | 21,967 | 19,250 | |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 35.18 | 802 | 28,214 | 16,844 | |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 30.28 | 657 | 19,894 | 5,906 | |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 32.07 | 1,214 | 38,933 | 14,901 | |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 135.76 | 4,052 | 550,100 | 34,618 | 38.7 K to 34.6 K (-10.48 %) |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 796 | 29,993 | 38,670 | 37.9 K to 38.7 K (+2.10 %) |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 583 | 21,967 | 37,874 | 37.3 K to 37.9 K (+1.56 %) |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 35.18 | 802 | 28,214 | 37,291 | 36.5 K to 37.3 K (+2.20 %) |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 30.28 | 657 | 19,894 | 36,489 | 35.8 K to 36.5 K (+1.83 %) |
Jul 10 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 32.07 | 1,214 | 38,933 | 35,832 | 34.6 K to 35.8 K (+3.51 %) |
Jul 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 132.80 | 308 | 40,902 | 48,838 | 49.1 K to 48.8 K (-0.63 %) |
Jul 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 132.80 | 1,243 | 165,070 | 48,961 | 50.2 K to 49 K (-2.48 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | S | 132.63 | 3,000 | 397,890 | 3,600 | 6.6 K to 3.6 K (-45.45 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Option Exercise | M | 28.55 | 25,375 | 724,456 | 2,625 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Sell | S | 132.63 | 25,375 | 3,365,486 | 32,083 | 57.5 K to 32.1 K (-44.16 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Buy | M | 28.55 | 25,375 | 724,456 | 57,458 | 32.1 K to 57.5 K (+79.09 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Sell | S | 132.63 | 3,000 | 397,890 | 3,600 | 6.6 K to 3.6 K (-45.45 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Sell | S | 132.63 | 2,000 | 265,260 | 6,600 | 8.6 K to 6.6 K (-23.26 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | M | 12.50 | 2,000 | 25,000 | 0 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | M | 28.41 | 4,000 | 113,640 | 1,000 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 132.63 | 2,500 | 331,575 | 14,890 | 17.4 K to 14.9 K (-14.38 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 131.92 | 3,500 | 461,703 | 17,390 | 20.9 K to 17.4 K (-16.75 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Buy | M | 28.41 | 4,000 | 113,640 | 20,890 | 16.9 K to 20.9 K (+23.68 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Buy | M | 12.50 | 2,000 | 25,000 | 16,890 | 14.9 K to 16.9 K (+13.43 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 28.55 | 273 | 7,794 | 0 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 37.68 | 719 | 27,092 | 16,291 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 35.18 | 547 | 19,243 | 8,021 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 30.28 | 765 | 23,164 | 5,104 | |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Sell | S | 132.63 | 2,304 | 305,580 | 19,374 | 21.7 K to 19.4 K (-10.63 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 28.55 | 273 | 7,794 | 21,678 | 21.4 K to 21.7 K (+1.28 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 37.68 | 719 | 27,092 | 21,405 | 20.7 K to 21.4 K (+3.48 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 35.18 | 547 | 19,243 | 20,686 | 20.1 K to 20.7 K (+2.72 %) |
Jul 02 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 30.28 | 765 | 23,164 | 20,139 | 19.4 K to 20.1 K (+3.95 %) |
Jun 21 2013 | ONXX | ONYX PHARMACEUTICA ... | Nevinny Corinne H | Director | Sell | S | 88.25 | 1,000 | 88,250 | 8,600 | 9.6 K to 8.6 K (-10.42 %) |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 28.55 | 274 | 7,823 | 273 | |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 30.28 | 219 | 6,631 | 5,869 | |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 37.68 | 719 | 27,092 | 17,010 | |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 35.18 | 547 | 19,243 | 8,568 | |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Option Exercise | M | 30.28 | 547 | 16,563 | 6,088 | |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Sell | S | 92.30 | 2,306 | 212,844 | 19,374 | 21.7 K to 19.4 K (-10.64 %) |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 28.55 | 274 | 7,823 | 21,680 | 21.4 K to 21.7 K (+1.28 %) |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 30.28 | 219 | 6,631 | 21,406 | 21.2 K to 21.4 K (+1.03 %) |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 37.68 | 719 | 27,092 | 21,187 | 20.5 K to 21.2 K (+3.51 %) |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 35.18 | 547 | 19,243 | 20,468 | 19.9 K to 20.5 K (+2.75 %) |
Jun 12 2013 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Public Affairs | Buy | M | 30.28 | 547 | 16,563 | 19,921 | 19.4 K to 19.9 K (+2.82 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 796 | 29,993 | 27,058 | |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 584 | 22,005 | 19,833 | |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 35.18 | 802 | 28,214 | 17,646 | |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 30.28 | 656 | 19,864 | 6,563 | |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 32.07 | 1,214 | 38,933 | 16,115 | |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 92.06 | 1,100 | 101,268 | 34,618 | 35.7 K to 34.6 K (-3.08 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 90.91 | 2,952 | 268,376 | 35,718 | 38.7 K to 35.7 K (-7.63 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 796 | 29,993 | 38,670 | 37.9 K to 38.7 K (+2.10 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 584 | 22,005 | 37,874 | 37.3 K to 37.9 K (+1.57 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 35.18 | 802 | 28,214 | 37,290 | 36.5 K to 37.3 K (+2.20 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 30.28 | 656 | 19,864 | 36,488 | 35.8 K to 36.5 K (+1.83 %) |
Jun 11 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 32.07 | 1,214 | 38,933 | 35,832 | 34.6 K to 35.8 K (+3.51 %) |
Jun 07 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Option Exercise | M | 35.18 | 6,562 | 230,851 | 48,125 | |
Jun 07 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Sell | S | 90.00 | 6,562 | 590,580 | 131,198 | 137.8 K to 131.2 K (-4.76 %) |
Jun 07 2013 | ONXX | ONYX PHARMACEUTICA ... | COLES N ANTHONY | Chairman & CEO | Buy | M | 35.18 | 6,562 | 230,851 | 137,760 | 131.2 K to 137.8 K (+5.00 %) |
May 23 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Gift | G | 0.00 | 850 | 0 | 8,115 | 9 K to 8.1 K (-9.48 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | M | 34.48 | 10,269 | 354,075 | 41,450 | |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 98.70 | 6,000 | 592,200 | 50,204 | 56.2 K to 50.2 K (-10.68 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 97.54 | 4,269 | 416,398 | 56,204 | 60.5 K to 56.2 K (-7.06 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Buy | M | 34.48 | 10,269 | 354,075 | 60,473 | 50.2 K to 60.5 K (+20.45 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 37.68 | 1,250 | 47,100 | 14,450 | |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 33.70 | 7,000 | 235,900 | 63,000 | |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 97.26 | 1,000 | 97,260 | 47,646 | 48.6 K to 47.6 K (-2.06 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 98.28 | 2,500 | 245,690 | 48,646 | 51.1 K to 48.6 K (-4.89 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 98.78 | 3,000 | 296,352 | 51,146 | 54.1 K to 51.1 K (-5.54 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 97.32 | 1,750 | 170,308 | 54,146 | 55.9 K to 54.1 K (-3.13 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 33.70 | 7,000 | 235,900 | 55,896 | 48.9 K to 55.9 K (+14.32 %) |
May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 37.68 | 1,250 | 47,100 | 48,896 | 47.6 K to 48.9 K (+2.62 %) |
May 16 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Sell | S | 97.13 | 1,194 | 115,979 | 32,083 | 33.3 K to 32.1 K (-3.59 %) |
May 16 2013 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corp. Dev & St ... | Sell | S | 96.38 | 2,988 | 287,988 | 33,277 | 36.3 K to 33.3 K (-8.24 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | M | 35.18 | 1,750 | 61,565 | 13,417 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | M | 37.68 | 2,387 | 89,942 | 27,854 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Option Exercise | M | 26.38 | 4,740 | 125,041 | 37,572 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Sell | S | 90.65 | 500 | 45,325 | 27,066 | 27.6 K to 27.1 K (-1.81 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Sell | S | 89.79 | 8,377 | 752,171 | 27,566 | 35.9 K to 27.6 K (-23.31 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Buy | M | 35.18 | 1,750 | 61,565 | 35,943 | 34.2 K to 35.9 K (+5.12 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Buy | M | 37.68 | 2,387 | 89,942 | 34,193 | 31.8 K to 34.2 K (+7.50 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | Foster-Cheek Kaye I | SVP, Global Human R ... | Buy | M | 26.38 | 4,740 | 125,041 | 31,806 | 27.1 K to 31.8 K (+17.51 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | M | 28.41 | 1,000 | 28,410 | 5,000 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 95.00 | 1,000 | 95,000 | 14,890 | 15.9 K to 14.9 K (-6.29 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Buy | M | 28.41 | 1,000 | 28,410 | 15,890 | 14.9 K to 15.9 K (+6.72 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 795 | 29,956 | 27,854 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 37.68 | 583 | 21,967 | 20,417 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 35.18 | 802 | 28,214 | 18,448 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 32.07 | 1,215 | 38,965 | 17,329 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Option Exercise | M | 30.28 | 656 | 19,864 | 7,219 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 90.01 | 1,378 | 124,034 | 34,618 | 36 K to 34.6 K (-3.83 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 89.99 | 802 | 72,172 | 35,996 | 36.8 K to 36 K (-2.18 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Sell | S | 89.94 | 1,871 | 168,278 | 36,798 | 38.7 K to 36.8 K (-4.84 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 795 | 29,956 | 38,669 | 37.9 K to 38.7 K (+2.10 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 37.68 | 583 | 21,967 | 37,874 | 37.3 K to 37.9 K (+1.56 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 35.18 | 802 | 28,214 | 37,291 | 36.5 K to 37.3 K (+2.20 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 32.07 | 1,215 | 38,965 | 36,489 | 35.3 K to 36.5 K (+3.44 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, GC and Corp. S ... | Buy | M | 30.28 | 656 | 19,864 | 35,274 | 34.6 K to 35.3 K (+1.89 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | M | 27.63 | 2,000 | 55,260 | 6,000 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Option Exercise | M | 25.30 | 2,500 | 63,250 | 0 | |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Sell | S | 91.01 | 4,500 | 409,545 | 8,965 | 13.5 K to 9 K (-33.42 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Buy | M | 27.63 | 2,000 | 55,260 | 13,465 | 11.5 K to 13.5 K (+17.44 %) |
May 08 2013 | ONXX | ONYX PHARMACEUTICA ... | WIGGANS THOMAS G | Director | Buy | M | 25.30 | 2,500 | 63,250 | 11,465 | 9 K to 11.5 K (+27.89 %) |
Apr 24 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 37.68 | 5,000 | 188,400 | 0 | |
Apr 24 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | S | 101.28 | 5,000 | 506,400 | 6,600 | 11.6 K to 6.6 K (-43.10 %) |
Apr 24 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 37.68 | 5,000 | 188,400 | 11,600 | 6.6 K to 11.6 K (+75.76 %) |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | M | 28.41 | 1,000 | 28,410 | 6,000 | |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | M | 12.50 | 4,000 | 50,000 | 2,000 | |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 94.08 | 200 | 18,816 | 14,890 | 15.1 K to 14.9 K (-1.33 %) |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 93.02 | 800 | 74,416 | 15,090 | 15.9 K to 15.1 K (-5.03 %) |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 93.85 | 1,000 | 93,845 | 15,890 | 16.9 K to 15.9 K (-5.92 %) |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Sell | S | 92.67 | 3,000 | 278,010 | 16,890 | 19.9 K to 16.9 K (-15.08 %) |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Buy | M | 28.41 | 1,000 | 28,410 | 19,890 | 18.9 K to 19.9 K (+5.29 %) |
May 03 2013 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Buy | M | 12.50 | 4,000 | 50,000 | 18,890 | 14.9 K to 18.9 K (+26.86 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 31.72 | 10,000 | 317,200 | 0 | |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 39.84 | 10,000 | 398,400 | 0 | |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 12.87 | 10,000 | 128,700 | 0 | |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 30.28 | 5,000 | 151,400 | 0 | |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 35.18 | 5,000 | 175,900 | 0 | |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Option Exercise | M | 28.55 | 3,164 | 90,332 | 0 | |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | S | 95.83 | 30,000 | 2,874,906 | 6,600 | 36.6 K to 6.6 K (-81.97 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 31.72 | 10,000 | 317,200 | 36,600 | 26.6 K to 36.6 K (+37.59 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 39.84 | 10,000 | 398,400 | 26,600 | 16.6 K to 26.6 K (+60.24 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 12.87 | 10,000 | 128,700 | 16,600 | 6.6 K to 16.6 K (+151.52 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Sell | S | 98.77 | 13,164 | 1,300,208 | 6,600 | 19.8 K to 6.6 K (-66.61 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 30.28 | 5,000 | 151,400 | 19,764 | 14.8 K to 19.8 K (+33.87 %) |
Apr 11 2013 | ONXX | ONYX PHARMACEUTICA ... | GRILLO LOPEZ ANTONIO J | Director | Buy | M | 35.18 | 5,000 | 175,900 | 14,764 | 9.8 K to 14.8 K (+51.21 %) |